Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

甲硫酸新斯的明注射液 - NMPA Drug Approval Details

Approvals/NMPA/Neostigmine Methylsulfate Injection

Approved

化学药品

Neostigmine Methylsulfate Injection

东阳祥昇医药科技有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 1, 2024
Approval ID: 8f0Qbscvt7S
Company: 东阳祥昇医药科技有限公司
Type: 化学药品

Approval Details

Approval Id: 8f0Qbscvt7S
Approval Number: 国药准字H20249617
Generic Name: 甲硫酸新斯的明注射液
Generic Name En: Neostigmine Methylsulfate Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 4ml:2mg
Reg Date: 2024-12-01
Company Name: 东阳祥昇医药科技有限公司
Company Address: 浙江省金华市东阳市江北街道猴塘社区广福东街23号总部中心B幢东楼502-1室
Production Company Name: 浙江北生药业汉生制药有限公司
Production Company Address: 浙江省东阳市江北高科技工业园区
Company Detail Path: /organization/aaab1beb4604cd21/dong-yang-xiang-sheng-yi-yao-ke-ji-you-xian-gong-si
Production Company Detail Path: /organization/ea78eda5a300fb59/zhe-jiang-bei-sheng-yao-ye-yi-sheng-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 1, 2024

Approval ID

8f0Qbscvt7S

Type

化学药品

Back to NMPA Approvals